Szabo et al. reported that treatment of nude mice with a CBS inhibitor could attenuate the growth of patient-derived colon cancer xenografts and reduce peritumoral blood flow (Szabo et al., 2013). This evidence concerns the gene CBS and malignant colon neoplasm.